Skip Ribbon Commands
Skip to main content

SUPPORTING YOUR SUCCESS FROM ACCESS TO CLOSURE

Terumo contributes to your procedural success, even with the most complex PCI patients

Presented as a Late Breaking Trial at EuroPCR 2021, the COLOR trial aims to investigate if transradial PCI with the use of 7F Glidesheath Slender™ is superior to transfemoral PCI, for complex coronary lesions requiring large bore guiding catheters. 

Learn more about the results of the COLOR Trial 


​Presented as a Late Breaking Trial at EuroPCR 2021, the COLOR trial aims to investigate if transradial PCI with the use of 7F Glidesheath Slender™ is superior to transfemoral PCI, for complex coronary lesions requiring large bore guiding catheters.

Learn more about the results of the COLOR Trial


Presented as a Late Breaking Trial at EuroPCR 2021, the COLOR trial aims to investigate if transradial PCI with the use of 7F Glidesheath Slender™ is superior to transfemoral PCI, for complex coronary lesions requiring large bore guiding catheters.

Learn more about the results of the COLOR Trial

Glidesheath Slender™ was the first introducer to propose a thin wall technology design enabling a 1Fr size outer diameter reduction, ensuring safe radial access for more patients. 

Learn more about Glidesheath Slender™ thin wall technology 

​Radial access is an evolving field, where the experiences of your peers may help you in your daily practice. Discover insights on very complex PCI management from Prof. Jim Nolan, Professor of cardiology at University Hospital of North Staffordshire, United Kingdom.


Learn more about Transradial Access for Complex PCI

What the evidence says

Discover our clinical evidence and case studies concerning this topic.

Do you need more info about this product?

Our sales representatives are here for you.

Contact us
Send us a message
 
I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*
I wish to receive information and marketing updates from Terumo.
* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public


For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.